AMN Healthcare Sells Smart Square Scheduling Technology to symplr, Creates Commercial Partnership to Deliver Comprehensive Healthcare Workforce Solutions

On July 2, 2025, AMN Healthcare (NYSE: AMN), a leader in comprehensive healthcare talent solutions, announced its sale of the Smart Square® scheduling software to symplr®, a prominent player in enterprise healthcare operations software. This strategic move not only involves the acquisition of the Smart Square technology but also establishes a commercial partnership aimed at providing integrated healthcare workforce solutions.

Cary Grace, president and CEO of AMN Healthcare, emphasized the growing complexity healthcare organizations face in workforce management. The collaboration will allow AMN to focus on enhancing its WorkWise platform, which integrates workforce planning, analytics, and artificial intelligence tools. By partnering with symplr, AMN aims to streamline workforce optimization, scheduling, and administrative functions for hospitals and health systems, facilitating a comprehensive solution tailored to modern demands.

BJ Schaknowski, CEO of symplr, highlighted the importance of equipping healthcare organizations with intelligent, purpose-built software to unlock the full potential of their technological investments. The incorporation of Smart Square’s AI-driven scheduling capabilities into the symplr Operations Platform will help address the evolving needs of the healthcare workforce effectively.

The agreement was valued at $75 million, with $65 million disbursed at closing and an additional $10 million note due by the end of 2026. This partnership marks a significant step towards delivering end-to-end workforce management solutions, combining AMN's advisory and talent acquisition prowess with symplr's operational efficiencies.

Both companies are committed to strengthening healthcare delivery and outcomes, as they explore new avenues for collaboration and innovation within the healthcare sector. For more information, visit AMN Healthcare's and symplr's websites.

On July 2, 2025, AMN Healthcare (NYSE: AMN) made a strategic move by selling its Smart Square® scheduling software to symplr® for $75 million. This deal is not merely a divestiture; it signals a significant commercial partnership that marries AMN's healthcare workforce solutions with symplr's operational software capabilities.

For investors, this development presents a crucial opportunity to reassess the potential of AMN in the healthcare sector. The integration of symplr's technology with AMN's existing WorkWise platform is poised to enhance the efficiency of healthcare organizations, addressing a pressing need for seamless workforce management solutions. This aligns with industry trends advocating for technological sophistication in workforce planning and analytics, particularly in a post-pandemic landscape where staffing complexities have escalated.

The financial implications of this partnership are substantial. The immediate cash influx of $65 million bolsters AMN's liquidity position, while the deferred note of $10 million showcases a commitment to a long-term relationship with symplr. This will likely enable AMN to invest in expanding its technological offerings, further solidifying its market leadership.

Moreover, the partnership enhances AMN's value proposition by delivering an end-to-end workforce management solution that leverages AI-driven insights—critical as healthcare organizations strive for operational excellence. As institutions increasingly seek integrated solutions, AMN's collaboration with symplr could enhance client retention and attract new business.

Given these developments, investors should view AMN as a robust player in the healthcare technology space. The stock may present growth potential as AMN capitalizes on this partnership to improve operational efficiencies for healthcare clients. Analysts should closely monitor subsequent earnings reports to gauge the financial impact of this newly formed alliance.